Aptose Biosciences Ownership 2024 | Who Owns Aptose Biosciences Now?

Overview RevenueFinancials Chart Transcripts

Institutional Ownership

0.39%

Insider Ownership

17.11%

Retail Ownership

82.50%

Institutional Holders

2.00

Aptose Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
DOHENY ASSET MANAGEMENT /CA	0.38%	0.18%	50,550	50,550	100.00%	319,000	Jun 30, 2024
CALDWELL SUTTER CAPITAL, INC.	0.00%	-	92	-	-	70	Jun 30, 2024
ANNANDALE CAPITAL, LLC	-	-	-	-26,666	-100.00%	-	Jun 30, 2024

Aptose Biosciences's largest institutional shareholder is DOHENY ASSET MANAGEMENT /CA, holding 0.38% of the company's total share outstanding, currently valued at $319.00K. The top 10 institutional shareholders own together 0.39% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
DOHENY ASSET MANAGEMENT /CA	0.38%	0.18%	50,550	50,550	100.00%	319,000	Jun 30, 2024
CALDWELL SUTTER CAPITAL, INC.	0.00%	-	92	-	-	70	Jun 30, 2024
ANNANDALE CAPITAL, LLC	-	-	-	-26,666	-100.00%	-	Jun 30, 2024

The largest Aptose Biosciences shareholder by % of total assets is DOHENY ASSET MANAGEMENT /CA. The company owns 50.55K shares of Aptose Biosciences (APTO), representing 0.18% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
DOHENY ASSET MANAGEMENT /CA	0.38%	0.18%	50,550	50,550	100.00%	319,000	Jun 30, 2024
CALDWELL SUTTER CAPITAL, INC.	0.00%	-	92	-	-	70	Jun 30, 2024
ANNANDALE CAPITAL, LLC	-	-	-	-26,666	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Aptose Biosciences's largest institutional buyer is DOHENY ASSET MANAGEMENT /CA. The company purchased 50.55K stocks of APTO, valued at $319.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ANNANDALE CAPITAL, LLC	-	-	-	-26,666	-100.00%	-	Jun 30, 2024
CALDWELL SUTTER CAPITAL, INC.	0.00%	-	92	-	-	70	Jun 30, 2024
DOHENY ASSET MANAGEMENT /CA	0.38%	0.18%	50,550	50,550	100.00%	319,000	Jun 30, 2024

As of Jun 30 2024, Aptose Biosciences's biggest institutional seller is ANNANDALE CAPITAL, LLC. The company sold -26.67K shares of APTO, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
DOHENY ASSET MANAGEMENT /CA	0.38%	0.18%	50,550	50,550	100.00%	319,000	Jun 30, 2024

Aptose Biosciences's largest new institutional shareholder by number of shares is DOHENY ASSET MANAGEMENT /CA, purchased 50.55K shares, valued at $319.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ANNANDALE CAPITAL, LLC	-	-	-	-26,666	-100.00%	-	Jun 30, 2024

Aptose Biosciences's largest sold out institutional shareholder by shares sold is ANNANDALE CAPITAL, LLC, sold -26.67K shares, valued at -, as of undefined.

Aptose Biosciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
DRIEHAUS MUTUAL FUNDS	0.02%	157,219	-	-	Mar 28, 2024
RBB FUND, INC.	0.00%	93,697	-	-	Feb 29, 2024
MUTUAL FUND SERIES TRUST	0.00%	2,299,000	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	32,455	-	-	Feb 29, 2024
Blackstone Alternative Investment Funds	0.00%	1,900	-300	-13.64%	Mar 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	2,162	-	-	Feb 29, 2024
DFA INVESTMENT TRUST CO	0.00%	767	-	-	Jan 31, 2024
DFA INVESTMENT TRUST CO	0.00%	766	-	-	Jan 31, 2024

Aptose Biosciences's largest mutual fund holder by % of total assets is "DRIEHAUS MUTUAL FUNDS", owning 157.22K shares, compromising 0.02% of its total assets.

Aptose Biosciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	2	-
31 Mar, 24	2	-
31 Dec, 23	2	-
30 Sep, 23	2	-
30 Jun, 23	2	-95.74%
31 Mar, 23	47	-9.62%
31 Dec, 22	52	1.96%
30 Sep, 22	51	-
30 Jun, 22	51	-8.93%
31 Mar, 22	56	-6.67%
31 Dec, 21	60	-11.76%
30 Sep, 21	68	-2.86%
30 Jun, 21	70	-11.39%
31 Mar, 21	79	9.72%
31 Dec, 20	72	4.35%
30 Sep, 20	69	13.11%
30 Jun, 20	61	5.17%
31 Mar, 20	58	-3.33%
31 Dec, 19	60	93.55%
30 Sep, 19	31	3.33%
30 Jun, 19	30	36.36%
31 Mar, 19	22	15.79%
31 Dec, 18	19	11.76%
30 Sep, 18	17	-15.00%
30 Jun, 18	20	25.00%
31 Mar, 18	16	14.29%
31 Dec, 17	14	27.27%
30 Sep, 17	11	22.22%
30 Jun, 17	9	-18.18%
31 Mar, 17	11	-8.33%
31 Dec, 16	12	20.00%
30 Sep, 16	10	-
30 Jun, 16	10	-16.67%
31 Mar, 16	12	9.09%
31 Dec, 15	11	-8.33%
30 Sep, 15	12	-25.00%
30 Jun, 15	16	23.08%
31 Mar, 15	13	85.71%
31 Dec, 14	7	-

As of 30 Jun 24, 2 institutions are holding Aptose Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	50,642	89.26%
31 Mar, 24	26,758	-64.21%
31 Dec, 23	74,758	-
30 Sep, 23	74,758	39.93%
30 Jun, 23	53,424	-99.75%
31 Mar, 23	21,229,689	-8.64%
31 Dec, 22	23,237,893	-5.82%
30 Sep, 22	24,674,082	-2.01%
30 Jun, 22	25,181,374	-12.08%
31 Mar, 22	28,642,615	-8.43%
31 Dec, 21	31,278,154	-21.02%
30 Sep, 21	39,601,723	-16.14%
30 Jun, 21	47,224,484	-9.82%
31 Mar, 21	52,368,085	7.50%
31 Dec, 20	48,716,550	4.98%
30 Sep, 20	46,405,649	29.18%
30 Jun, 20	35,923,088	2.15%
31 Mar, 20	35,166,763	14.50%
31 Dec, 19	30,713,615	116.20%
30 Sep, 19	14,205,906	19.18%
30 Jun, 19	11,919,893	261.89%
31 Mar, 19	3,293,821	6.54%
31 Dec, 18	3,091,651	149.37%
30 Sep, 18	1,239,771	48.73%
30 Jun, 18	833,559	74.19%
31 Mar, 18	478,530	33.02%
31 Dec, 17	359,752	68.70%
30 Sep, 17	213,254	-80.37%
30 Jun, 17	1,086,453	-55.26%
31 Mar, 17	2,428,382	-9.73%
31 Dec, 16	2,690,112	-7.24%
30 Sep, 16	2,899,922	15.80%
30 Jun, 16	2,504,257	-4.72%
31 Mar, 16	2,628,228	-0.20%
31 Dec, 15	2,633,617	-4.28%
30 Sep, 15	2,751,269	-12.18%
30 Jun, 15	3,132,731	7.21%
31 Mar, 15	2,921,982	-7.49%
31 Dec, 14	3,158,683	-

Aptose Biosciences (APTO) has 50.64K shares outstanding as of 30 Jun 24, up 89.26% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	0.39%	245.77%
31 Mar, 24	0.40%	29.90%
31 Dec, 23	1.15%	0.36%
30 Sep, 23	17.99%	540135.36%
30 Jun, 23	0.06%	2.47%
31 Mar, 23	1.53%	54.24%
31 Dec, 22	1.68%	52.85%
30 Sep, 22	1.78%	53.82%
30 Jun, 22	1.82%	42.45%
31 Mar, 22	2.07%	37.79%
31 Dec, 21	2.34%	26.57%
30 Sep, 21	2.97%	23.69%
30 Jun, 21	3.54%	22.94%
31 Mar, 21	3.93%	24.94%
31 Dec, 20	3.97%	30.57%
30 Sep, 20	3.60%	36.55%
30 Jun, 20	3.14%	33.19%
31 Mar, 20	3.08%	18.46%
31 Dec, 19	4.08%	139.96%
30 Sep, 19	1.71%	58.41%
30 Jun, 19	1.71%	563.02%
31 Mar, 19	0.55%	144.63%
31 Dec, 18	0.62%	1080.75%
30 Sep, 18	0.24%	891.81%
30 Jun, 18	0.16%	1357.10%
31 Mar, 18	0.11%	950.70%
31 Dec, 17	0.11%	3078.00%
30 Sep, 17	0.06%	52.60%
30 Jun, 17	0.34%	38.81%
31 Mar, 17	0.93%	46.92%
31 Dec, 16	1.41%	62.49%
30 Sep, 16	1.50%	80.55%
30 Jun, 16	1.36%	64.54%
31 Mar, 16	1.45%	66.87%
31 Dec, 15	1.47%	62.17%
30 Sep, 15	1.54%	50.08%
30 Jun, 15	1.75%	64.29%
31 Mar, 15	1.65%	50.38%
31 Dec, 14	1.81%	-

As of 30 Jun 24, Aptose Biosciences is held by 0.39% institutional shareholders, representing a 245.77% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	1	-
31 Mar, 24	-	-
31 Dec, 23	-	-100.00%
30 Sep, 23	1	-
30 Jun, 23	1	-88.89%
31 Mar, 23	9	-62.50%
31 Dec, 22	24	41.18%
30 Sep, 22	17	41.67%
30 Jun, 22	12	-42.86%
31 Mar, 22	21	-36.36%
31 Dec, 21	33	-
30 Sep, 21	33	22.22%
30 Jun, 21	27	-35.71%
31 Mar, 21	42	10.53%
31 Dec, 20	38	-17.39%
30 Sep, 20	46	43.75%
30 Jun, 20	32	-3.03%
31 Mar, 20	33	-31.25%
31 Dec, 19	48	118.18%
30 Sep, 19	22	-
30 Jun, 19	22	69.23%
31 Mar, 19	13	44.44%
31 Dec, 18	9	12.50%
30 Sep, 18	8	-33.33%
30 Jun, 18	12	33.33%
31 Mar, 18	9	12.50%
31 Dec, 17	8	33.33%
30 Sep, 17	6	100.00%
30 Jun, 17	3	-50.00%
31 Mar, 17	6	20.00%
31 Dec, 16	5	-16.67%
30 Sep, 16	6	100.00%
30 Jun, 16	3	-25.00%
31 Mar, 16	4	-20.00%
31 Dec, 15	5	400.00%
30 Sep, 15	1	-87.50%
30 Jun, 15	8	-11.11%
31 Mar, 15	9	28.57%
31 Dec, 14	7	-

1 institutional shareholders have increased their position in APTO stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-100.00%
31 Mar, 24	1	-
31 Dec, 23	-	-
30 Sep, 23	-	-100.00%
30 Jun, 23	1	-92.86%
31 Mar, 23	14	27.27%
31 Dec, 22	11	-8.33%
30 Sep, 22	12	-20.00%
30 Jun, 22	15	7.14%
31 Mar, 22	14	-
31 Dec, 21	14	-33.33%
30 Sep, 21	21	16.67%
30 Jun, 21	18	-5.26%
31 Mar, 21	19	11.76%
31 Dec, 20	17	54.55%
30 Sep, 20	11	-31.25%
30 Jun, 20	16	14.29%
31 Mar, 20	14	100.00%
31 Dec, 19	7	75.00%
30 Sep, 19	4	33.33%
30 Jun, 19	3	-25.00%
31 Mar, 19	4	-
31 Dec, 18	4	-
30 Sep, 18	4	-
30 Jun, 18	4	-
31 Mar, 18	4	33.33%
31 Dec, 17	3	-25.00%
30 Sep, 17	4	-
30 Jun, 17	4	100.00%
31 Mar, 17	2	-66.67%
31 Dec, 16	6	500.00%
30 Sep, 16	1	-66.67%
30 Jun, 16	3	-
31 Mar, 16	3	50.00%
31 Dec, 15	2	-71.43%
30 Sep, 15	7	133.33%
30 Jun, 15	3	50.00%
31 Mar, 15	2	-
31 Dec, 14	-	-

- institutional shareholders have reduced their position in APTO stock as of 30 Jun 24 compared to 1 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	2	-	50,642	89.26%	0.39%	245.77%	1	-	-	-100.00%
31 Mar, 24	2	-	26,758	-64.21%	0.40%	29.90%	-	-	1	-
31 Dec, 23	2	-	74,758	-	1.15%	0.36%	-	-100.00%	-	-
30 Sep, 23	2	-	74,758	39.93%	17.99%	540135.36%	1	-	-	-100.00%
30 Jun, 23	2	-95.74%	53,424	-99.75%	0.06%	2.47%	1	-88.89%	1	-92.86%
31 Mar, 23	47	-9.62%	21,229,689	-8.64%	1.53%	54.24%	9	-62.50%	14	27.27%
31 Dec, 22	52	1.96%	23,237,893	-5.82%	1.68%	52.85%	24	41.18%	11	-8.33%
30 Sep, 22	51	-	24,674,082	-2.01%	1.78%	53.82%	17	41.67%	12	-20.00%
30 Jun, 22	51	-8.93%	25,181,374	-12.08%	1.82%	42.45%	12	-42.86%	15	7.14%
31 Mar, 22	56	-6.67%	28,642,615	-8.43%	2.07%	37.79%	21	-36.36%	14	-
31 Dec, 21	60	-11.76%	31,278,154	-21.02%	2.34%	26.57%	33	-	14	-33.33%
30 Sep, 21	68	-2.86%	39,601,723	-16.14%	2.97%	23.69%	33	22.22%	21	16.67%
30 Jun, 21	70	-11.39%	47,224,484	-9.82%	3.54%	22.94%	27	-35.71%	18	-5.26%
31 Mar, 21	79	9.72%	52,368,085	7.50%	3.93%	24.94%	42	10.53%	19	11.76%
31 Dec, 20	72	4.35%	48,716,550	4.98%	3.97%	30.57%	38	-17.39%	17	54.55%
30 Sep, 20	69	13.11%	46,405,649	29.18%	3.60%	36.55%	46	43.75%	11	-31.25%
30 Jun, 20	61	5.17%	35,923,088	2.15%	3.14%	33.19%	32	-3.03%	16	14.29%
31 Mar, 20	58	-3.33%	35,166,763	14.50%	3.08%	18.46%	33	-31.25%	14	100.00%
31 Dec, 19	60	93.55%	30,713,615	116.20%	4.08%	139.96%	48	118.18%	7	75.00%
30 Sep, 19	31	3.33%	14,205,906	19.18%	1.71%	58.41%	22	-	4	33.33%
30 Jun, 19	30	36.36%	11,919,893	261.89%	1.71%	563.02%	22	69.23%	3	-25.00%
31 Mar, 19	22	15.79%	3,293,821	6.54%	0.55%	144.63%	13	44.44%	4	-
31 Dec, 18	19	11.76%	3,091,651	149.37%	0.62%	1080.75%	9	12.50%	4	-
30 Sep, 18	17	-15.00%	1,239,771	48.73%	0.24%	891.81%	8	-33.33%	4	-
30 Jun, 18	20	25.00%	833,559	74.19%	0.16%	1357.10%	12	33.33%	4	-
31 Mar, 18	16	14.29%	478,530	33.02%	0.11%	950.70%	9	12.50%	4	33.33%
31 Dec, 17	14	27.27%	359,752	68.70%	0.11%	3078.00%	8	33.33%	3	-25.00%
30 Sep, 17	11	22.22%	213,254	-80.37%	0.06%	52.60%	6	100.00%	4	-
30 Jun, 17	9	-18.18%	1,086,453	-55.26%	0.34%	38.81%	3	-50.00%	4	100.00%
31 Mar, 17	11	-8.33%	2,428,382	-9.73%	0.93%	46.92%	6	20.00%	2	-66.67%
31 Dec, 16	12	20.00%	2,690,112	-7.24%	1.41%	62.49%	5	-16.67%	6	500.00%
30 Sep, 16	10	-	2,899,922	15.80%	1.50%	80.55%	6	100.00%	1	-66.67%
30 Jun, 16	10	-16.67%	2,504,257	-4.72%	1.36%	64.54%	3	-25.00%	3	-
31 Mar, 16	12	9.09%	2,628,228	-0.20%	1.45%	66.87%	4	-20.00%	3	50.00%
31 Dec, 15	11	-8.33%	2,633,617	-4.28%	1.47%	62.17%	5	400.00%	2	-71.43%
30 Sep, 15	12	-25.00%	2,751,269	-12.18%	1.54%	50.08%	1	-87.50%	7	133.33%
30 Jun, 15	16	23.08%	3,132,731	7.21%	1.75%	64.29%	8	-11.11%	3	50.00%
31 Mar, 15	13	85.71%	2,921,982	-7.49%	1.65%	50.38%	9	28.57%	2	-
31 Dec, 14	7	-	3,158,683	-	1.81%	-	7	-	-	-

Aptose Biosciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 25, 2023	Seizinger Bernd R.	director	-	P-Purchase	Buy	17,000	$3.14	$53.38K	17,000

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 25, 2023	Seizinger Bernd R.	director	-	P-Purchase	Buy	17,000	$3.14	$53.38K	17,000

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 10, 2024	LEDRU PHILIPPE		-		Buy	-	-	-	-
Feb 07, 2024	Payne Fletcher	officer	Sr VP and CFO	A-Award	Buy	55,000	$2.00	$110.00K	55,000
Feb 07, 2024	Bejar Rafael	officer	Sr VP & Chief Medical Officer	A-Award	Buy	35,000	$2.00	$70.00K	35,000
Feb 07, 2024	LEDRU PHILIPPE	officer	Sr VP & Ch Commerical Officer	A-Award	Buy	11,000	$2.00	$22.00K	11,000
Feb 07, 2024	Rice William G.	director, officer	Chair, President & CEO	A-Award	Buy	70,000	$2.00	$140.00K	70,000
Feb 07, 2024	Seizinger Bernd R.	director	-	A-Award	Buy	3,333	$2.00	$6.67K	3,333
Feb 07, 2024	PLATZER ERICH	director	-	A-Award	Buy	3,333	$2.00	$6.67K	3,333
Feb 07, 2024	Vincent Mark D.	director	-	A-Award	Buy	3,333	$1.97	$6.57K	3,333
Feb 07, 2024	Ashe Carol Gail	director	-	A-Award	Buy	3,333	$2.00	$6.67K	3,333
Feb 07, 2024	BURGER DENIS R	director	-	A-Award	Buy	3,333	$2.00	$6.67K	3,333
Feb 07, 2024	Whitehead Warren	director	-	A-Award	Buy	3,333	$1.97	$6.57K	3,333
Sep 25, 2023	Seizinger Bernd R.	director	-	P-Purchase	Buy	17,000	$3.14	$53.38K	17,000
Jan 23, 2023	Whitehead Warren	director	-	A-Award	Buy	100,000	-	-	100,000
Jan 23, 2023	Vincent Mark D.	director	-	A-Award	Buy	100,000	-	-	100,000
Jan 23, 2023	Seizinger Bernd R.	director	-	A-Award	Buy	100,000	-	-	100,000
Jan 23, 2023	Rice William G.	officer	Chair, President & CEO	A-Award	Buy	150,000	-	-	513,252
Jan 23, 2023	Rice William G.	officer	Chair, President & CEO	A-Award	Buy	400,000	-	-	400,000
Jan 23, 2023	PLATZER ERICH	director	-	A-Award	Buy	100,000	-	-	100,000
Jan 23, 2023	Payne Fletcher	officer	SR VP & Chief Fin. Officer	A-Award	Buy	200,000	-	-	200,000
Jan 23, 2023	Payne Fletcher	officer	SR VP & Chief Fin. Officer	A-Award	Buy	100,000	-	-	100,000

The last insider buy of APTO was made by Seizinger Bernd R. on Sep 25 2023, buying 17,000 shares at $3.14 per share (worth $53.38K).

Aptose Biosciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2027	-	1	-
Q1 2024	10	-	-
Q3 2023	1	-	-
Q1 2023	14	-	-
Q3 2022	4	-	-
Q2 2022	3	1	300.00%
Q1 2022	9	-	-
Q4 2021	14	2	700.00%
Q3 2021	4	1	400.00%
Q2 2021	-	2	-
Q1 2021	10	-	-
Q4 2020	1	3	33.33%
Q3 2020	-	4	-
Q2 2020	12	4	300.00%
Q1 2020	28	-	-
Q4 2019	1	-	-
Q2 2019	4	1	400.00%
Q1 2019	15	-	-
Q4 2018	-	6	-
Q3 2018	-	1	-

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Aptose Biosciences's insiders, as of Q2 2027.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2027	-	-	-
Q1 2024	-	-	-
Q3 2023	1	-	-
Q1 2023	-	-	-
Q3 2022	1	-	-
Q2 2022	1	-	-
Q1 2022	-	-	-
Q4 2021	12	-	-
Q3 2021	2	1	200.00%
Q2 2021	-	2	-
Q1 2021	-	-	-
Q4 2020	-	2	-
Q3 2020	-	4	-
Q2 2020	-	4	-
Q1 2020	1	-	-
Q4 2019	1	-	-
Q2 2019	2	-	-
Q1 2019	5	2	250.00%
Q4 2018	-	-	-
Q3 2018	-	-	-

As of Q2 2027, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Aptose Biosciences's stocks.

Aptose Biosciences Peer Ownership

Ticker	Company
ACHL	Achilles Therapeutics plc
ONCT	Oncternal Therapeutics, Inc.
CTMX	CytomX Therapeutics, Inc.
ADAP	Adaptimmune Therapeutics plc
SPRO	Spero Therapeutics, Inc.
FBIO	Fortress Biotech, Inc.
CRVS	Corvus Pharmaceuticals, Inc.
GANX	Gain Therapeutics, Inc.
LTRN	Lantern Pharma Inc.
ASMB	Assembly Biosciences, Inc.
AFMD	Affimed N.V.
TFFP	TFF Pharmaceuticals, Inc.
INAB	IN8bio, Inc.
MBIO	Mustang Bio, Inc.
LPTX	Leap Therapeutics, Inc.
AGLE	Spyre Therapeutics, Inc.
NLTX	Neurogene Inc.
LIFE	aTyr Pharma, Inc.
TIL	Instil Bio, Inc.
LBPH	Longboard Pharmaceuticals, Inc.

APTO Ownership FAQ

Who Owns Aptose Biosciences?

Aptose Biosciences is owned by institutional shareholders (0.39%), insiders (17.11%), and public (82.50%). The largest institutional shareholder of Aptose Biosciences is DOHENY ASSET MANAGEMENT /CA (0.38% of total shares) and the top mutual fund owner is DRIEHAUS MUTUAL FUNDS (0.02% of total shares).

Who are the major institutional shareholders of Aptose Biosciences?

Aptose Biosciences's major institutional shareholders are DOHENY ASSET MANAGEMENT /CA, CALDWELL SUTTER CAPITAL, INC., and ANNANDALE CAPITAL, LLC. The top five shareholders own together 0.39% of the company's share outstanding.

How many Aptose Biosciences shareholders are there?

As of Jun 2024, there are 2 institutional shareholders of Aptose Biosciences.

What percentage of Aptose Biosciences is owned by DOHENY ASSET MANAGEMENT /CA?

DOHENY ASSET MANAGEMENT /CA owns 50.55K shares of Aptose Biosciences, representing 0.38% of the company's total shares outstanding, valued at $319K (as of Jun 2024).

What percentage of Aptose Biosciences is owned by CALDWELL SUTTER CAPITAL, INC?

As of Jun 2024, CALDWELL SUTTER CAPITAL, INC holds 92 shares of Aptose Biosciences (APTO), compromising 0.00% of the company, valued at $70.

What percentage of Aptose Biosciences is owned by ANNANDALE CAPITAL, LLC?

ANNANDALE CAPITAL, LLC is the third largest holder of Aptose Biosciences. The company owns 0 of the company's shares outstanding (worth $0).